Brind.

Vision Analytical Inc. presents flow imaging system for drug particle analysis

1 report, 1 independent Updated Oct 19
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Vision Analytical Inc., a manufacturer based in MIaMI, presented the Raptor 1788 flow imaging system at the PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Palm Springs. The system is designed for subvisible particle characterization in parenteral drug products, including prefilled syringes, biologics, and vaccines. The Raptor 1788 allows for direct, non-destructive analysis straight from the syringe, with resolution down to 1 µm.

From news-medical.net

Why it matters

Some supportBrind's analysis of the reports

The presentation addresses the challenge of distinguishing lubricant droplets from protein aggregates in prefilled syringes, which are a primary format for biologics. The system helps meet regulatory standards, such as USP <788>, by providing morphology-based classification of particles.

From news-medical.net

Who's involved

  • MIaMIManufacturer of Dynamic Image Analysis instruments

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • MIaMISpeculative

    Pharmaceutical and biotech manufacturers might be able to improve product quality control and reduce manufacturing costs by using advanced particle characterization methods.

Possible ripples

Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped